Cargando…

Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis

BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare multisystemic disorder with various clinical manifestations. Despite the recognition of several prognostic factors, the long-term clinical course and prognosis of patients with LAM in the era of sirolimus therapy are not established. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Hee-Young, Kim, Ho Jeong, Song, Jin Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206248/ https://www.ncbi.nlm.nih.gov/pubmed/35717210 http://dx.doi.org/10.1186/s12931-022-02079-6

Ejemplares similares

Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea
por: Chang, Shihwan, et al.
Publicado: (2022)

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis
por: Hu, Siqi, et al.
Publicado: (2019)

Long-term clinical course and outcome in patients with primary Sjögren syndrome-associated interstitial lung disease
por: Kim, Yun Jae, et al.
Publicado: (2021)

Sarcoid-like reaction in patients with malignant tumors: Long-term clinical course and outcomes
por: Huh, Jin-Young, et al.
Publicado: (2022)

Long-term clinical course and outcomes of immunoglobulin G4-related lung disease
por: Kang, Jieun, et al.
Publicado: (2020)

Clinical features and outcomes of male patients with lymphangioleiomyomatosis: A review
por: Zhang, Haoyu, et al.
Publicado: (2022)

Long-term clinical course and outcomes of patients with microscopic polyangiitis-associated interstitial lung disease
por: Kim, Min Jee, et al.
Publicado: (2023)

A Nationwide Survey of Lymphangioleiomyomatosis in Korea: Recent Increase in Newly Diagnosed Patients
por: Park, Hye Yun, et al.
Publicado: (2010)

Lymphangioleiomyomatosis: a clinical review
por: O'Mahony, Anne M., et al.
Publicado: (2020)

Congenital Aniridia: Long-term Clinical Course, Visual Outcome, and Prognostic Factors
por: Chang, Ji Woong, et al.
Publicado: (2014)

Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response
por: Miller, Suzanne, et al.
Publicado: (2020)

Management of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M., et al.
Publicado: (2014)

Lymphangioleiomyomatosis (LAM)
Publicado: (2017)

Pulmonary lymphangioleiomyomatosis in a male.
por: Kang, H. W., et al.
Publicado: (1991)

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2015)

Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience
por: Revilla-López, Eva, et al.
Publicado: (2021)

Methylprednisolone in the treatment of lymphangioleiomyomatosis
por: Dale, Ventour, et al.
Publicado: (2022)

Chylothorax, in the Spotlight of Lymphangioleiomyomatosis
por: Gámez-Baeza, Pablo, et al.
Publicado: (2022)

Treatment of lymphangioleiomyomatosis and Camões
por: Rufino, Rogério
Publicado: (2015)

Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis
por: Chang, William YC, et al.
Publicado: (2012)

Role of Prolactin Receptors in Lymphangioleiomyomatosis
por: Alkharusi, Amira, et al.
Publicado: (2016)

Lung Transplantation for Lymphangioleiomyomatosis in Japan
por: Ando, Katsutoshi, et al.
Publicado: (2016)

YouTube-videos for patient education in lymphangioleiomyomatosis?
por: Wilkens, Finn M., et al.
Publicado: (2022)

Transudative chylothorax in a patient with lymphangioleiomyomatosis
por: Noriega Aldave, Adrian Pedro, et al.
Publicado: (2017)

Bioinformatics analysis of inflammation and oncology in pulmonary lymphangioleiomyomatosis
por: Su, Wanchun, et al.
Publicado: (2022)

Possible Novel Therapeutic Targets in Lymphangioleiomyomatosis Treatment
por: Song, Xixi, et al.
Publicado: (2020)

A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes
por: Zhang, Ji, et al.
Publicado: (2021)

Air travel and incidence of pneumothorax in lymphangioleiomyomatosis
por: Gonano, Cynthia, et al.
Publicado: (2018)

The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis
por: Wang, Qi, et al.
Publicado: (2020)

Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM)
por: Shen, Lisha, et al.
Publicado: (2021)

Lymphangioleiomyomatosis Presenting with Perirenal Hemorrhage
por: Dekeyzer, S., et al.
Publicado: (2015)

Recent advances in the management of lymphangioleiomyomatosis
por: Xu, Kai-Feng, et al.
Publicado: (2018)

Lymphangioleiomyomatosis Presenting as Recurrent Pneumothorax
por: Odak, Mihir, et al.
Publicado: (2020)

Lymphangioleiomyomatosis: Searching for potential biomarkers
por: Revilla-López, Eva, et al.
Publicado: (2023)

Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
por: Kim, Nam Hee, et al.
Publicado: (2014)

“Getting stuck with LAM”: patients perspectives on living with Lymphangioleiomyomatosis
por: Belkin, Amanda, et al.
Publicado: (2014)

Long-Term Clinical Course of Normal-Tension Glaucoma: 20 Years of Experience
por: Jin, Sang Wook, et al.
Publicado: (2017)

Long-term clinical outcomes and predictive factors in patients with chronic ocular graft-versus-host disease
por: Yoon, Hyeon-Jeong, et al.
Publicado: (2022)

Perioperative management of thoracic surgery in patients with lymphangioleiomyomatosis
por: Fukui, Mariko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pacmlfcb69g5n4671b2soiq8u0